A successful immunisation program that yields robust immunity with the lowest possible performance consequences requires the formulation of a consistent vaccine based on viable sporulated oocyst counts. These counts can accurately be made by means of an assay that detects the proportion of non-viable sporocysts in the original oocyst population. This article can also be found in World Poultry, Coccidiosis 4 Join 31,000+ subscribers Subscribe to our newsletter to
Get full access to all stories on Poultry World
This Premium article is exclusively available for subscribers
Obtain insights from exclusive interviews
Dive into articles covering trending industry topics
Get a glimpse into poultry farms worldwide
All the news is brought to you by experienced editors and experts from around the world